Nutrients

Nutritional Status and Cognition in Older Adults: Modification by Apolipoprotein E ε4

Figure 1. Standardized regression coefficients (β) of MNA scores for the prediction of CERAD total score (TS), overall and by APOE4 status, from the fully adjusted Model 2.
Open the figure at full size
Figure 1. Standardized regression coefficients (β) of MNA scores for the prediction of CERAD total score (TS), overall and by APOE4 status, from the fully adjusted Model…Standardized regression coefficients (β) of MNA scores for the prediction of CERAD total score (TS), overall and by APOE4 status, from the fully adjusted Model 2.Choe et al.
Cross-sectional study of 196 peoplePopulations
Follow

Abstract

Background: Malnutrition is a modifiable risk factor for late-life cognitive decline, but whether its cognitive correlates vary by genetic risk is unclear. We examined whether the apolipoprotein E ε4 allele (APOE4) modifies associations of the Mini-Nutritional Assessment (MNA) and its subscales with global cognition. Methods: In this cross-sectional analysis of 196 non-demented older Korean adults from the General Lifestyle and Alzheimer's Disease (GLAD) cohort, multiple linear regression tested associations of MNA total (MNA-T), screening (MNA-S), and assessment (MNA-A) scores with the CERAD total score (TS), including MNA × APOE4 interactions. Exploratory analyses examined one representative item per a priori nutritional domain. Results: After adjustment, MNA-T (p = 0.006) and MNA-A (p = 0.003), but not MNA-S (p = 0.065), were associated with TS. APOE4 carrier status modified these associations (interaction p = 0.005 and 0.007, respectively); associations were evident in non-carriers but not in carriers, an underpowered subgroup (n = 40). Among the domain-representative items, only self-rated health survived Bonferroni correction (p = 0.006); protein intake (p = 0.025) and calf circumference (p = 0.043) showed nominal associations only. Conclusions: Better nutritional status was associated with better global cognition, predominantly in APOE4 non-carriers. These hypothesis-generating findings require confirmation in larger longitudinal and interventional studies.